Related Experiment Video
Updated: Feb 3, 2026
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Improving Care in Pediatric Inflammatory Bowel Disease
Matthew D Egberg1, Michael D Kappelman2, Ajay S Gulati3
1Department of Pediatrics, University of North Carolina at Chapel Hill, 130 Mason Farm Road, Bioinformatics Building, CB# 7229, Chapel Hill, NC 27599, USA.
Insights
Quality improvement (QI) can enhance care for pediatric inflammatory bowel disease (IBD) patients. This review explores QI history, challenges, and initiatives to improve pediatric IBD outcomes.
Area of Science:
- Pediatric gastroenterology
- Healthcare quality improvement
- Chronic disease management
Background:
- Pediatric inflammatory bowel disease (IBD) is a chronic condition requiring extensive healthcare engagement and high-risk treatments.
- Quality improvement (QI) methodologies have demonstrably enhanced healthcare delivery and reliability.
- Despite QI advancements, significant gaps remain in delivering optimal care for pediatric IBD patients.
Purpose of the Study:
- To provide a historical overview of healthcare QI.
- To identify current challenges and deficits in pediatric IBD care.
- To highlight existing QI initiatives and propose future directions for improving pediatric IBD outcomes.
Main Methods:
- Literature review of healthcare QI history.
- Analysis of identified gaps in pediatric IBD care delivery.
- Review and synthesis of current pediatric IBD QI initiatives.
Main Results:
- Healthcare QI has a documented history of improving care quality and reliability.
- Persistent deficits exist in the quality of care provided to pediatric IBD patients.
- Several QI initiatives have been implemented, with varying degrees of success.
Conclusions:
- Pediatric IBD patients can significantly benefit from targeted QI strategies.
- Addressing identified gaps and challenges is crucial for enhancing pediatric IBD care.
- Continued focus on QI initiatives is essential for improving long-term outcomes in pediatric IBD.
Abstract:
Pediatric patients with inflammatory bowel disease (IBD) stand to benefit from quality improvement (QI) due to the chronic nature of the disease, frequent interaction with the health care system, and exposure to high-risk treatments. The use of QI in health care has led to significant improvements in quality and reliability of care. Despite these advances, significant deficits in providing high-quality pediatric IBD care persist. This article describes a brief history of health care QI, identifies gaps and challenges in delivery of quality pediatric IBD care, highlights several IBD QI initiatives, and concludes with future directions for improving pediatric IBD outcomes.
More Related Videos
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Coronary Artery Disease V: Interprofessional Care